Peranan Paromomycin untuk Amebiasis
Abstract
Full Text:
PDFReferences
vanHal SJ, Stark DJ, Fotedar R, Marriott D, Ellis JT, Harkness JL. Amoebiasis: current status in Australia. MJA 2007; 186: 412–416.
Anorital, Andayasari L. Kajian epidemiologi penyakit infeksi saluran pencernaan yang disebabkan oleh amuba di Indonesia. Media Litbang Kesehatan 2011;21(1).
Pritt BS, Clark CG. Amebiasis. Mayo Clin Proc. 2008;83(10):1154-60.
Roy SL. Infectious diseases related to travel. CDC. 2013.
Salles JM, Salles MJ, Moraes LA. Invasive amoebiasis, an update on diagnosis and management. Expert Rev Anti Infect Ther. 2007;5(5):893- 901.
Petri WA. Therapy of intestinal protozoa. Trends in Parasitology 2003. Available from: http://zoologia.biologia.uasnet.mx/protozoos/protozoa9.pdf
Dhawan VK, Cleveland KO, Cantey JR, Amebiasis medication. Medscape [Internet] 2014 [Cited 2014 Aug 14]. available from: http://emedicine.medscape.com/article/212029-medication#showall
Paromomycin sulfate [Internet] 2014 [Cited 2014 Aug 14]. Available from: http://www.rxlist.com/paromomycin-sulfate-drug/indications-dosage.htm
Paromomycin sulfate [Internet] 2013 [Cited 2015 Sept 30]. Available from:http://www.drugs.com/pro/paromomycin.html
Paromomycin. Wikipedia [Internet] 2015 [Cited 2015 Sept 29]. Available from: https://en.wikipedia.org/wiki/Paromomycin_sulfate
Gabbryl. [package insert]. Jakarta: PT. Kalbe Farma Tbk; 2011.
Kikuchia T, Kogaa M, Shimizua S, Miuraa T, Maruyamab H, Kimurac M. Efficacy and safety of paromomycin for treating amebiasis in Japan. Parasitology Internat 2013;62(6): 497–501.
Refbacks
- There are currently no refbacks.